Autologous effector lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous effector lymphocytes, covering 2017-10-24 to 2017-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy [Phase 2]